Top of Notices Top of Notices   (425)  December 30, 2014 US PATENT AND TRADEMARK OFFICE Print This Notice 1409 CNOG  2690 

PCT, International Applications Referenced Items (410, 411, 412, 413, 414, 415, 416, 417, 418, 419, 420, 421, 422, 423, 424, 425, 426, 427, 428, 429, 430, 431)
(425)                Notice Concerning EPO Competence to
                            Act as a PCT Authority

   The European Patent Office (EPO) has notified the International
Bureau of the World Intellectual Property Organization (WIPO) and the
United States Patent and Trademark Office (USPTO) that the EPO will
limit their competence to act as both an International Searching
Authority and an International Preliminary Examining Authority for
certain applications filed by applicants who are residents or nationals
United States (US).

   The EPO will no longer be a competent International Searching
Authority (ISA), within the meaning of PCT Article 16(3), for
international applications filed by US residents or nationals on or
after 01 March 2002 in the USPTO or International Bureau (IB) as
receiving Office, and where the application contains one or more claims
directed to the fields of biotechnology or business methods. For the
definition of what the EPO considers to be precluded subject matter in
the fields of biotechnology and business methods, applicants should see
the "Notice from the President of the European Patent Office,"
dated 26 November 2001, and which is attached to this Notice as Annex
A.

   The EPO will no longer be a competent International Preliminary
Examining Authority (IPEA), within the meaning of PCT Article 32(3),
for international applications filed by US residents or nationals in
the USPTO or IB as receiving Office where the corresponding demand is
filed with the EPO on or after 01 March 2002, and where the application
contains one or more claims directed to the fields of biotechnology,
business methods or telecommunication. For the definition of what the
EPO considers to be precluded subject matter in the field of
telecommunication, applicants should see the "Notice from the
President of the European Patent Office," dated 26 November 2001, and
which is attached to this Notice as Annex A. This limitation applies to
all demands received at the EPO on or after 01 March 2002 including
demands in applications that were filed before 01 March 2002 for which
the EPO was still the competent ISA.

   Residents or nationals of the US should not select the
EPO as the ISA/IPEA when filing applications in the above-listed
technologies. The classification of an international application
is a function of the ISA (PCT Rule 43.3(b)), and as such, the United
States Receiving Office (RO/US) has neither the resources nor the
authority to determine if applications fall within the above
International Patent Classification Units. Therefore, the RO/US
will rely solely on applicant determinations as to the area of
classification and the resulting competency of the EPO, and as such,
the RO/US will forward all applications in which the EPO is indicated
as the ISA/IPEA in our normal course of doing business.

   The EPO has not published any procedures outlining their intent
to refund any fees in applications where the EPO determines that it is
not competent. If the application is forwarded to the ISA/US
under these conditions, applicant will be required to pay the current
fees required by the RO/US in order to avoid withdrawal of
the international application.

   The USPTO understands that the EPO will perform international
searches and international preliminary examinations for residents and
nationals of the US in applications where the applicant has either
filed a concurrent Euro-direct application or has requested concurrent
regional stage entry in the EPO regardless of whether the application
is directed to subject matter in one of the precluded areas of
technology.

Top of Notices Top of Notices   (425)  December 30, 2014 US PATENT AND TRADEMARK OFFICE 1409 CNOG  2691 

   Those applicants who would be filing demands in the EPO or the
USPTO solely for the purpose of extending the deadline for national
stage entry from twenty (20) to thirty (30) months should note that
this may no longer be necessary, as discussed below.

   The PCT Assembly decided to amend the time limits in PCT
Article 22(1) for entry into the national stage from 20 to 30 months
from the earliest priority date, effective 01 April 2002. Subject to
the following paragraph, this new time limit applies to international
applications in respect of which the period of 20 months from the
earliest priority date expires on or after 01 April 2002.

   Since a number of countries will have to modify their national
law to implement this change, the IB has provided transitional
arrangements that will allow each country to postpone enactment so long
as notice is provided to the IB by 31 January 2002. In countries that
find it necessary to postpone enactment, an applicant wishing to
benefit from the 30-month time limit must file a demand before the 19
months from the earliest priority date. However, if the countries in
which applicant desires to enter the national stage do not have such
transitional arrangements, and the applicant desires merely to delay
national stage entry to 30 months from the earliest priority date, it
will no longer be necessary for applicant to file a demand.

January 16, 2002                                           STEPHEN G. KUNIN
                                                    Deputy Commissioner for
                                                  Patent Examination Policy

Annex A

Notice from the President of the European Patent Office dated 26
November 2001 concerning limitation of the EPO's competence as a PCT
authority

Limitation criteria

1. Pursuant to Article 3(4)(a)(ii) of the PCT Agreement between
the European Patent Organisation and the International Bureau of the
World Intellectual Property Organization, as amended with effect from 1
November 2001 (OJ EPO 2001,601), the European Patent Office
(EPO) will not carry out

(a) international search in respect of any
international application filed on or after 1 March 2002 by
a national or resident of the United States of America with the
United States Patent and Trademark Office (USPTO) or the
International Bureau (IB) as receiving Office where such
application contains one or more claims relating to the fields of
biotechnology or business methods, as defined by the International
Patent Classification units indicated below in paragraphs 3 and 4.

(b) international preliminary examination in respect
of any international application filed by a national or resident
of the United States of America with the USPTO or the IB as
receiving Office where the corresponding demand is filed with the
EPO on or after 1 March 2002 and the application contains one or
more claims relating to the fields of biotechnology or business
methods as referred to in sub-paragraph (a) above or to the
field of telecommunication as defined by the International
Patent Classification unit indicated below in paragraph 5.

2. Without prejudice to the right of the EPO to issue any further
notice under Article 3(4) of the PCT Agreement which it may consider
necessary, the initial duration of these limitations will be three
years (Article 3(4)(c) of the PCT Agreement).

Top of Notices Top of Notices   (425)  December 30, 2014 US PATENT AND TRADEMARK OFFICE 1409 CNOG  2692 

International Patent Classification

3. Biotechnology

C12M        Apparatus for enzymology or microbiology
C12N        Micro-organisms or enzymes; compositions thereof
C12P        Fermentation or enzyme-using processes to synthesise a desired
            chemical compound or composition or to separate optical isomers
            from a racemic mixture
C12Q        Measuring or testing processes involving enzymes or
            micro-organisms; compositions or test papers therefor;
            processes of preparing such compositions;
            condition-responsive control in microbiological or
            enzymological processes
C07K        Peptides
G01N33/50   (including subdivisions) Chemical analysis of biological
            material, e.g. blood, urine; testing involving biospecific
            ligand binding methods; immunological testing A61K39 Medicinal
            preparations containing antigens or antibodies
A61K48      Medicinal preparations containing genetic material which is
            inserted into cells of the living body to treat genetic
            diseases; gene therapy
A01H        New plants or processes for obtaining them; plant
            reproduction by tissue culture techniques

            For information: US classes covering corresponding
            subject-matter
            424    Drug, bio-affecting and body treating
                   compositions
            435    Chemistry: molecular biology and
                   microbiology
            436    Chemistry: analytical and immunological
                   testing
            514    Drug, bio-affecting and body treating
                   compositions
            530    Chemistry: natural resins or derivatives; peptides or
                   proteins; lignins or reaction products thereof
            536    Organic compounds-part of the class 532-570 series
            800    Multicellular living organisms and unmodified
                   parts thereof
            930    Peptide or protein sequence

4. Business method related inventions

GO6F17/60   Digital computing or data processing equipment or methods,
            specially adapted for specific functions: administrative,
            commercial, managerial, supervisory or forecasting purposes. If
            an application falls within this subgroup but does not relate
            to business methods, the EPO's competence is not affected.

            For information: US class covering corresponding subject-matter
            705    Data processing: financial, business practice,
                   management, or cost/price determination

5. Telecommunication

H04         Electric communication technique with the exception
            of H04N: pictorial communication, e.g. television

            For information: US classes covering corresponding
            subject-matter
            370    Multiplex communications
            375    Pulse or digital communications 379 Telephonic
                   communication
            380    Cryptography
            381    Electrical audio signal processing systems and devices
Top of Notices Top of Notices   (425)  December 30, 2014 US PATENT AND TRADEMARK OFFICE 1409 CNOG  2693 

            455    Telecommunications

Notes

6. The EPO is no longer the competent authority within the
meaning of Article 16(3)(b)1 and Article 32(3) PCT for applications
meeting the criteria defined in paragraph 1.

7. Paragraph 1 also applies to applications filed with the IB
rather than the USPTO by two or more applicants,

   - at least one of whom is a national or resident of the USA,
and
   - none of whom are nationals or residents of an EPC contracting state.

8. It is not possible to reassign competence to the EPO by
changing the applicant after the application has been filed with the
USPTO or the IB.

9. The limitation criteria in paragraph 1(b) apply to all demands
for international preliminary examination received at the EPO on or
after 1 March 2002 (sic), which means they are also applicable to
applications filed before 1 March 2002 for which the EPO was still the
competent International Searching Authority.

1 The receiving Office deletes the indication of
any non-competent International Searching Authority ex officio
(Receiving Office Guidelines, No. 115, PCT Gazette - IV, 29 of 17
September 1998).

2 Demands for international preliminary
examination submitted to a non-competent authority are subject to Rule
59.3 PCT.

                                  [1255 OG 878]